Keita Hattori - Publications

Evaluation of Puromycin-Induced Podocyte Injury and Protective Effects of Voclosporin Using Induced Pluripotent Stem Cells from a Patient with Nephrotic Syndrome Harboring an INF2 Variant.

Journal: Stem cells and development

Published: June 18, 2026

Larger balloon diameter improves vascular resistance in arteriovenous access: A retrospective analysis.

Journal: The International journal of artificial organs

Published: June 08, 2026

Generation of a human-induced pluripotent stem cell line (NUMNi003-A) from a patient with autosomal dominant polycystic kidney disease harboring a PKD1 gene variant.

Journal: Stem cell research

Published: February 24, 2026

YS-1301 ameliorates crescentic glomerulonephritis by promoting immunoregulatory macrophages.

Journal: BMC nephrology

Published: December 10, 2025

Amnion-derived mesenchymal stem cells attenuate anti-GBM glomerulonephritis via regulation of neutrophil CD44 expression.

Journal: Stem cell research & therapy

Published: October 26, 2025

Frequency of Home Therapy Among Patients Who Underwent Kidney Transplantation Followed by Maintenance Dialysis.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: August 30, 2025

Serum Magnesium Levels as a Prognostic Marker in Emergency Department Admissions: A Landmark Retrospective Cohort Study.

Journal: Journal of the American College of Emergency Physicians open

Published: August 20, 2025

Novel fixative solutions with superior preservation of structure and antigenicity are suitable for optical clearing, tissue staining, and flow cytometry.

Journal: Nagoya journal of medical science

Published: June 30, 2025

Generation of a human iPSC line (NUMNi002-A) from a patient with nephrotic syndrome harboring an INF2 gene variant.

Journal: Stem cell research

Published: June 12, 2025

Establishment of the NUMNi001-A human iPSC line from peripheral blood mononuclear cells of a healthy male donor.

Journal: Stem cell research

Published: March 24, 2025

Erratum: In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney.

Journal: Molecular therapy. Nucleic acids

Published: March 14, 2025

Urinary presepsin can efficiently detect T-cell-mediated rejection in patients who have undergone kidney transplantation.

Journal: Clinical and experimental nephrology

Published: February 05, 2025